Italian Medicines Agency withdraws GMP certificate

Canadian importers have agreed to quarantine health products made with active pharmaceutical ingredients (APIs) from Indian drug maker Sri Krishna Pharmaceuticals, due to data integrity concerns. The Italian Medicines Agency withdrew the Good Manufacturing Practice (GMP) certificate of Sri Krishna Pharmaceuticals, citing 10 GMP deviations found during an inspection in early December.